Clinical Trial

Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age.

Study acronym: MELA_2025
Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of the study is to analyse a local cohort of patients aged 18-39 years with melanoma diagnosis in order to determine the prevalence of the disease in this age group. Secondary objectives are the following: * To identify risk factors associated with melanoma in young people. * To characterise the phenotype and dermoscopic features of melanoma in patients aged 18-39 years. * To analyse the relationship between the clinical and histopathological features of melanoma in young people. * To identify the mutational status of B-RAF in the sample of patients analysed.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-05-20; most recent amendment 2025-12-18.
Status change: Not Yet Recruiting → Recruiting 2025-12-18
Trial Details
NCT Number NCT06994208
Lead Sponsor Ente Ospedaliero Ospedali Galliera
Conditions Melanoma of Skin
Enrollment 25 participants
Start Date 2025-12-02
Primary Completion 2027-09-01 (estimated)
Study Completion 2028-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-19